Adventrx, SD Pharma deal

ANX will acquire reformulation company SD Pharmaceuticals for 2.1 million shares, or $10.3 million based on ANX's close of $4.89 on April 7, the last trading day before the deal was announced. The deal gives ANX eight preclinical oncology and infectious disease compounds. ...